Fenofibrate Protects Cardiomyocytes from Hypoxia/Reperfusion- and High Glucose-Induced Detrimental Effects

Lesions caused by high glucose (HG), hypoxia/reperfusion (H/R), and the coexistence of both conditions in cardiomyocytes are linked to an overproduction of reactive oxygen species (ROS), causing irreversible damage to macromolecules in the cardiomyocyte as well as its ultrastructure. Fenofibrate, a...

Full description

Saved in:
Bibliographic Details
Main Authors: Fabiola Cortes-Lopez, Alicia Sanchez-Mendoza, David Centurion, Luz G. Cervantes-Perez, Vicente Castrejon-Tellez, Leonardo del Valle-Mondragon, Elizabeth Soria-Castro, Victoria Ramirez, Araceli Sanchez-Lopez, Gustavo Pastelin-Hernandez, Wylly Ramses Garcia-Niño, Maria Sanchez-Aguilar, Luz Ibarra-Lara
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:PPAR Research
Online Access:http://dx.doi.org/10.1155/2021/8895376
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552873531015168
author Fabiola Cortes-Lopez
Alicia Sanchez-Mendoza
David Centurion
Luz G. Cervantes-Perez
Vicente Castrejon-Tellez
Leonardo del Valle-Mondragon
Elizabeth Soria-Castro
Victoria Ramirez
Araceli Sanchez-Lopez
Gustavo Pastelin-Hernandez
Wylly Ramses Garcia-Niño
Maria Sanchez-Aguilar
Luz Ibarra-Lara
author_facet Fabiola Cortes-Lopez
Alicia Sanchez-Mendoza
David Centurion
Luz G. Cervantes-Perez
Vicente Castrejon-Tellez
Leonardo del Valle-Mondragon
Elizabeth Soria-Castro
Victoria Ramirez
Araceli Sanchez-Lopez
Gustavo Pastelin-Hernandez
Wylly Ramses Garcia-Niño
Maria Sanchez-Aguilar
Luz Ibarra-Lara
author_sort Fabiola Cortes-Lopez
collection DOAJ
description Lesions caused by high glucose (HG), hypoxia/reperfusion (H/R), and the coexistence of both conditions in cardiomyocytes are linked to an overproduction of reactive oxygen species (ROS), causing irreversible damage to macromolecules in the cardiomyocyte as well as its ultrastructure. Fenofibrate, a peroxisome proliferator-activated receptor alpha (PPARα) agonist, promotes beneficial activities counteracting cardiac injury. Therefore, the objective of this work was to determine the potential protective effect of fenofibrate in cardiomyocytes exposed to HG, H/R, and HG+H/R. Cardiomyocyte cultures were divided into four main groups: (1) control (CT), (2) HG (25 mM), (3) H/R, and (4) HG+H/R. Our results indicate that cell viability decreases in cardiomyocytes undergoing HG, H/R, and both conditions, while fenofibrate improves cell viability in every case. Fenofibrate also decreases ROS production as well as nicotinamide adenine dinucleotide phosphate oxidase (NADPH) subunit expression. Regarding the antioxidant defense, superoxide dismutase (SOD Cu2+/Zn2+ and SOD Mn2+), catalase, and the antioxidant capacity were decreased in HG, H/R, and HG+H/R-exposed cardiomyocytes, while fenofibrate increased those parameters. The expression of nuclear factor erythroid 2-related factor 2 (Nrf2) increased significantly in treated cells, while pathologies increased the expression of its inhibitor Keap1. Oxidative stress-induced mitochondrial damage was lower in fenofibrate-exposed cardiomyocytes. Endothelial nitric oxide synthase was also favored in cardiomyocytes treated with fenofibrate. Our results suggest that fenofibrate preserves the antioxidant status and the ultrastructure in cardiomyocytes undergoing HG, H/R, and HG+H/R preventing damage to essential macromolecules involved in the proper functioning of the cardiomyocyte.
format Article
id doaj-art-aa7200dbb9c940e7afef92f1148b5b46
institution Kabale University
issn 1687-4757
1687-4765
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series PPAR Research
spelling doaj-art-aa7200dbb9c940e7afef92f1148b5b462025-02-03T05:57:35ZengWileyPPAR Research1687-47571687-47652021-01-01202110.1155/2021/88953768895376Fenofibrate Protects Cardiomyocytes from Hypoxia/Reperfusion- and High Glucose-Induced Detrimental EffectsFabiola Cortes-Lopez0Alicia Sanchez-Mendoza1David Centurion2Luz G. Cervantes-Perez3Vicente Castrejon-Tellez4Leonardo del Valle-Mondragon5Elizabeth Soria-Castro6Victoria Ramirez7Araceli Sanchez-Lopez8Gustavo Pastelin-Hernandez9Wylly Ramses Garcia-Niño10Maria Sanchez-Aguilar11Luz Ibarra-Lara12Department of Pharmacobiology, Center for Research and Advanced Studies of the National Polytechnic Institute, Calz. de los Tenorios 235, Col Granjas Coapa, Tlalpan, 14330 Mexico City, MexicoDepartment of Pharmacology, National Institute of Cardiology Ignacio Chávez, Juan Badiano No. 1, Col. Sección XVI, Tlalpan, 14080 Mexico City, MexicoDepartment of Pharmacobiology, Center for Research and Advanced Studies of the National Polytechnic Institute, Calz. de los Tenorios 235, Col Granjas Coapa, Tlalpan, 14330 Mexico City, MexicoDepartment of Pharmacology, National Institute of Cardiology Ignacio Chávez, Juan Badiano No. 1, Col. Sección XVI, Tlalpan, 14080 Mexico City, MexicoDepartment of Physiology, National Institute of Cardiology Ignacio Chávez, Mexico City, MexicoDepartment of Pharmacology, National Institute of Cardiology Ignacio Chávez, Juan Badiano No. 1, Col. Sección XVI, Tlalpan, 14080 Mexico City, MexicoDepartment of Cardiovascular Biomedicine, National Institute of Cardiology Ignacio Chávez, Mexico City, MexicoDepartment of Experimental Surgery, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Vasco de Quiroga 15, Belisario Domínguez, Col. Sección XVI, Tlalpan, 14080 Mexico City, MexicoDepartment of Pharmacobiology, Center for Research and Advanced Studies of the National Polytechnic Institute, Calz. de los Tenorios 235, Col Granjas Coapa, Tlalpan, 14330 Mexico City, MexicoDepartment of Pharmacology, National Institute of Cardiology Ignacio Chávez, Juan Badiano No. 1, Col. Sección XVI, Tlalpan, 14080 Mexico City, MexicoDepartment of Cardiovascular Biomedicine, National Institute of Cardiology Ignacio Chávez, Mexico City, MexicoDepartment of Pharmacology, National Institute of Cardiology Ignacio Chávez, Juan Badiano No. 1, Col. Sección XVI, Tlalpan, 14080 Mexico City, MexicoDepartment of Pharmacology, National Institute of Cardiology Ignacio Chávez, Juan Badiano No. 1, Col. Sección XVI, Tlalpan, 14080 Mexico City, MexicoLesions caused by high glucose (HG), hypoxia/reperfusion (H/R), and the coexistence of both conditions in cardiomyocytes are linked to an overproduction of reactive oxygen species (ROS), causing irreversible damage to macromolecules in the cardiomyocyte as well as its ultrastructure. Fenofibrate, a peroxisome proliferator-activated receptor alpha (PPARα) agonist, promotes beneficial activities counteracting cardiac injury. Therefore, the objective of this work was to determine the potential protective effect of fenofibrate in cardiomyocytes exposed to HG, H/R, and HG+H/R. Cardiomyocyte cultures were divided into four main groups: (1) control (CT), (2) HG (25 mM), (3) H/R, and (4) HG+H/R. Our results indicate that cell viability decreases in cardiomyocytes undergoing HG, H/R, and both conditions, while fenofibrate improves cell viability in every case. Fenofibrate also decreases ROS production as well as nicotinamide adenine dinucleotide phosphate oxidase (NADPH) subunit expression. Regarding the antioxidant defense, superoxide dismutase (SOD Cu2+/Zn2+ and SOD Mn2+), catalase, and the antioxidant capacity were decreased in HG, H/R, and HG+H/R-exposed cardiomyocytes, while fenofibrate increased those parameters. The expression of nuclear factor erythroid 2-related factor 2 (Nrf2) increased significantly in treated cells, while pathologies increased the expression of its inhibitor Keap1. Oxidative stress-induced mitochondrial damage was lower in fenofibrate-exposed cardiomyocytes. Endothelial nitric oxide synthase was also favored in cardiomyocytes treated with fenofibrate. Our results suggest that fenofibrate preserves the antioxidant status and the ultrastructure in cardiomyocytes undergoing HG, H/R, and HG+H/R preventing damage to essential macromolecules involved in the proper functioning of the cardiomyocyte.http://dx.doi.org/10.1155/2021/8895376
spellingShingle Fabiola Cortes-Lopez
Alicia Sanchez-Mendoza
David Centurion
Luz G. Cervantes-Perez
Vicente Castrejon-Tellez
Leonardo del Valle-Mondragon
Elizabeth Soria-Castro
Victoria Ramirez
Araceli Sanchez-Lopez
Gustavo Pastelin-Hernandez
Wylly Ramses Garcia-Niño
Maria Sanchez-Aguilar
Luz Ibarra-Lara
Fenofibrate Protects Cardiomyocytes from Hypoxia/Reperfusion- and High Glucose-Induced Detrimental Effects
PPAR Research
title Fenofibrate Protects Cardiomyocytes from Hypoxia/Reperfusion- and High Glucose-Induced Detrimental Effects
title_full Fenofibrate Protects Cardiomyocytes from Hypoxia/Reperfusion- and High Glucose-Induced Detrimental Effects
title_fullStr Fenofibrate Protects Cardiomyocytes from Hypoxia/Reperfusion- and High Glucose-Induced Detrimental Effects
title_full_unstemmed Fenofibrate Protects Cardiomyocytes from Hypoxia/Reperfusion- and High Glucose-Induced Detrimental Effects
title_short Fenofibrate Protects Cardiomyocytes from Hypoxia/Reperfusion- and High Glucose-Induced Detrimental Effects
title_sort fenofibrate protects cardiomyocytes from hypoxia reperfusion and high glucose induced detrimental effects
url http://dx.doi.org/10.1155/2021/8895376
work_keys_str_mv AT fabiolacorteslopez fenofibrateprotectscardiomyocytesfromhypoxiareperfusionandhighglucoseinduceddetrimentaleffects
AT aliciasanchezmendoza fenofibrateprotectscardiomyocytesfromhypoxiareperfusionandhighglucoseinduceddetrimentaleffects
AT davidcenturion fenofibrateprotectscardiomyocytesfromhypoxiareperfusionandhighglucoseinduceddetrimentaleffects
AT luzgcervantesperez fenofibrateprotectscardiomyocytesfromhypoxiareperfusionandhighglucoseinduceddetrimentaleffects
AT vicentecastrejontellez fenofibrateprotectscardiomyocytesfromhypoxiareperfusionandhighglucoseinduceddetrimentaleffects
AT leonardodelvallemondragon fenofibrateprotectscardiomyocytesfromhypoxiareperfusionandhighglucoseinduceddetrimentaleffects
AT elizabethsoriacastro fenofibrateprotectscardiomyocytesfromhypoxiareperfusionandhighglucoseinduceddetrimentaleffects
AT victoriaramirez fenofibrateprotectscardiomyocytesfromhypoxiareperfusionandhighglucoseinduceddetrimentaleffects
AT aracelisanchezlopez fenofibrateprotectscardiomyocytesfromhypoxiareperfusionandhighglucoseinduceddetrimentaleffects
AT gustavopastelinhernandez fenofibrateprotectscardiomyocytesfromhypoxiareperfusionandhighglucoseinduceddetrimentaleffects
AT wyllyramsesgarcianino fenofibrateprotectscardiomyocytesfromhypoxiareperfusionandhighglucoseinduceddetrimentaleffects
AT mariasanchezaguilar fenofibrateprotectscardiomyocytesfromhypoxiareperfusionandhighglucoseinduceddetrimentaleffects
AT luzibarralara fenofibrateprotectscardiomyocytesfromhypoxiareperfusionandhighglucoseinduceddetrimentaleffects